Testosterone Restores Body Composition, Bone Mass, and Bone Strength Following Early Puberty Suppression in a Mouse Model Mimicking the Clinical Strategy in Trans Boys
Journal of Bone and Mineral Research · 2023
DOI: 10.1002/jbmr.4832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Research, 2023. Verfasst von Vanessa Dubois und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (Chrometa), KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Testosterone, Body Composition, Bone Density, Bone and Bones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Transgender youth increasingly present at pediatric gender services. Some of them receive long-term puberty suppression with gonadotropin-releasing hormone analogues (GnRHa) before starting gender-affirming hormones (GAH). The impact of GnRHa use started in early puberty on bone composition and bone mass accrual is unexplored. It is furthermore unclear whether subsequent GAH fully restore GnRHa effects and whether the timing of GAH introduction matters. To answer these questions, we developed a mouse model mimicking the clinical strategy applied in trans boys. Prepubertal 4-week-old female mice were treated with GnRHa alone or with GnRHa supplemented with testosterone (T) from 6 weeks (early puberty) or 8 weeks (late puberty) onward. Outcomes were analyzed at 16 weeks and compared with untreated mice of both sexes. GnRHa markedly increased total body fat mass, decreased lean body mass, and had a modest negative impact on grip strength. Both early and late T administration shaped body composition to adult male levels, whereas grip strength was restored to female values. GnRHa-treated animals showed lower trabecular bone volume and reduced cortical bone mass and strength. These changes were reversed by T to female levels (cortical bone mass and strength) irrespective of the time of administration or even fully up to adult male control values (trabecular parameters) in case of earlier T start. The lower bone mass in GnRHa-treated mice was associated with increased bone marrow adiposity, also reversed by T. In conclusion, prolonged GnRHa use started in prepubertal female mice modifies body composition toward more fat and less lean mass and impairs bone mass acquisition and strength. Subsequent T administration counteracts GnRHa impact on these parameters, shaping body composition and trabecular parameters to male values while restoring cortical bone architecture and strength up to female but not male control levels. These findings could help guide clinical strategies in transgender care. © 2023 American Society for Bone and Mineral Research (ASBMR). Abstract Prolonged puberty suppression with gonadotropin-releasing hormone analogue (GnRHa) impacts body composition and skeletal characteristics in a mouse model mimicking the clinical strategy in trans boys. Some parameters are fully reversed to control male levels by gender-affirming hormone (GAH), for trabecular bone volume upon early but not late addition, whereas other parameters including cortical bone mass and strength only reach female values, irrespective of the time of testosterone administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (Chrometa), KU Leuven, Leuven, Belgium.
- Basic and Translational Endocrinology (BaTE), Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium.
- Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
- Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
- Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
- Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
ORCID-Profile: Vanessa Dubois, Silvia Ciancia, Stefanie Doms, Sarah El Kharraz, Karel David, Roger Valle-Tenney, Christa Maes, Leen Antonio, Brigitte Decallonne, Geert Carmeliet, Frank Claessens, Martine Cools
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Dubois, V., Ciancia, S., Doms, S., El Kharraz, S., Sommers, V., Kim, N. R., David, K., Van Dijck, J., Valle-Tenney, R., Maes, C., Antonio, L., Decallonne, B., Carmeliet, G., Claessens, F., Cools, M., & Vanderschueren, D. (2023). Testosterone Restores Body Composition, Bone Mass, and Bone Strength Following Early Puberty Suppression in a Mouse Model Mimicking the Clinical Strategy in Trans Boys. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.4832
Vancouver
Dubois V, Ciancia S, Doms S, El Kharraz S, Sommers V, Kim NR, et al. Testosterone Restores Body Composition, Bone Mass, and Bone Strength Following Early Puberty Suppression in a Mouse Model Mimicking the Clinical Strategy in Trans Boys. Journal of Bone and Mineral Research. 2023. doi:10.1002/jbmr.4832
BibTeX
@article{Dubois2023,
author = {Dubois, Vanessa and Ciancia, Silvia and Doms, Stefanie and El Kharraz, Sarah and Sommers, Vera and Kim, Na Ri and David, Karel and Van Dijck, Jolien and Valle-Tenney, Roger and Maes, Christa and Antonio, Leen and Decallonne, Brigitte and Carmeliet, Geert and Claessens, Frank and Cools, Martine and Vanderschueren, Dirk},
title = {Testosterone Restores Body Composition, Bone Mass, and Bone Strength Following Early Puberty Suppression in a Mouse Model Mimicking the Clinical Strategy in Trans Boys},
journal = {Journal of Bone and Mineral Research},
year = {2023},
doi = {10.1002/jbmr.4832}
}
EUVIMED